Neurocrine Biosciences Bolsters Leadership Team for Growth Phase
Event summary
- Neurocrine Biosciences appointed Bret Paulson as Senior Vice President, Market Access on July 23, 2026.
- David Bradfute and Aaron Vosburgh were promoted to Senior Vice President roles in Intellectual Property and Finance & Accounting, respectively.
- The moves aim to support Neurocrine's expansion into a diversified, multi-product biopharmaceutical company.
The big picture
Neurocrine Biosciences is strengthening its leadership team to execute its next phase of growth, expanding its commercial portfolio and advancing one of the industry's strongest neuroscience pipelines. The company aims to deliver sustainable long-term growth by diversifying into a multi-product biopharmaceutical player. These strategic hires and promotions reflect Neurocrine's evolution as it prepares to bring more innovative medicines to patients.
What we're watching
- Market Access Strategy
- How Bret Paulson's experience will shape Neurocrine's global market access vision and payer partnerships.
- Intellectual Property Protection
- Whether David Bradfute can effectively oversee the protection of Neurocrine's diversified portfolio and scientific innovations.
- Financial Strategy
- The pace at which Aaron Vosburgh aligns capital allocation with Neurocrine's long-range financial planning and portfolio investments.